Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 286641

Weekly docetaxel doses in dctx/estm therapy followed by vp-16/estm treatment in Stage D3 patients with GS>6.


Tarle, Marko; Kovačić, Ksenija; Kraljić, Ivo.
Weekly docetaxel doses in dctx/estm therapy followed by vp-16/estm treatment in Stage D3 patients with GS>6. // Program Book and Abstracts, Fall Joint SBUR-ESUR Meeting, December 1-4, 2005. / Shuk-Mei Ho, PhD, Univ of Cincinnati Med Center (ur.).
Cincinnati: SBUR, Society for Basic Urologic Research, 2005. str. 150-150 (poster, međunarodna recenzija, sažetak, ostalo)


CROSBI ID: 286641 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Weekly docetaxel doses in dctx/estm therapy followed by vp-16/estm treatment in Stage D3 patients with GS>6.

Autori
Tarle, Marko ; Kovačić, Ksenija ; Kraljić, Ivo.

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, ostalo

Izvornik
Program Book and Abstracts, Fall Joint SBUR-ESUR Meeting, December 1-4, 2005. / Shuk-Mei Ho, PhD, Univ of Cincinnati Med Center - Cincinnati : SBUR, Society for Basic Urologic Research, 2005, 150-150

Skup
Fall Joint SBUR-ESUR Meeting, December 1-4, 2005.

Mjesto i datum
Miami Beach, Florida, SAD, December 1-4, 2005

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
docetaxel combination therapies; weekly vs. q3w doses; differential scintigraphy

Sažetak
In distinguishing between weekly vs. q3w docetaxel doses applied to HRPC patients we used differential bone scintigrapy in patients with <20 lesions in bone by attributing to every lesion progression , stablization or remission status and thus recording the overall response in bone. We found that approach as exceedingly useful in differentiating progression from a stable disease of remission and thus the neccessity to change the therapy applaid,

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Projekti:
0134003

Ustanove:
KBC "Sestre Milosrdnice"


Citiraj ovu publikaciju:

Tarle, Marko; Kovačić, Ksenija; Kraljić, Ivo.
Weekly docetaxel doses in dctx/estm therapy followed by vp-16/estm treatment in Stage D3 patients with GS>6. // Program Book and Abstracts, Fall Joint SBUR-ESUR Meeting, December 1-4, 2005. / Shuk-Mei Ho, PhD, Univ of Cincinnati Med Center (ur.).
Cincinnati: SBUR, Society for Basic Urologic Research, 2005. str. 150-150 (poster, međunarodna recenzija, sažetak, ostalo)
Tarle, M., Kovačić, K. & Kraljić, I. (2005) Weekly docetaxel doses in dctx/estm therapy followed by vp-16/estm treatment in Stage D3 patients with GS>6.. U: Shuk-Mei Ho, PhD, Univ of Cincinnati Med Center (ur.)Program Book and Abstracts, Fall Joint SBUR-ESUR Meeting, December 1-4, 2005..
@article{article, author = {Tarle, Marko and Kova\v{c}i\'{c}, Ksenija and Kralji\'{c}, Ivo.}, year = {2005}, pages = {150-150}, keywords = {docetaxel combination therapies, weekly vs. q3w doses, differential scintigraphy}, title = {Weekly docetaxel doses in dctx/estm therapy followed by vp-16/estm treatment in Stage D3 patients with GS>6.}, keyword = {docetaxel combination therapies, weekly vs. q3w doses, differential scintigraphy}, publisher = {SBUR, Society for Basic Urologic Research}, publisherplace = {Miami Beach, Florida, SAD} }
@article{article, author = {Tarle, Marko and Kova\v{c}i\'{c}, Ksenija and Kralji\'{c}, Ivo.}, year = {2005}, pages = {150-150}, keywords = {docetaxel combination therapies, weekly vs. q3w doses, differential scintigraphy}, title = {Weekly docetaxel doses in dctx/estm therapy followed by vp-16/estm treatment in Stage D3 patients with GS>6.}, keyword = {docetaxel combination therapies, weekly vs. q3w doses, differential scintigraphy}, publisher = {SBUR, Society for Basic Urologic Research}, publisherplace = {Miami Beach, Florida, SAD} }




Contrast
Increase Font
Decrease Font
Dyslexic Font